Aktien aus dem Gesundheitswesen
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4796 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.18 USD | +5.31% | +172.50% | +61.48% | -18.35% | 5.54 M USD | ||
| 4803 |  NVNO enVVeno Medical Corporation - Common Stock | 7.93 USD | +9.53% | -5.71% | -13.71% | +929.87% | 5.41 M USD | ||
| 4804 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.82 USD | +6.49% | -4.65% | -4.65% | -79.45% | 5.41 M USD | ||
| 4811 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.78 USD | +6.59% | -6.32% | -11.00% | -32.06% | 5.27 M USD | ||
| 4813 |  AIM AIM ImmunoTech Inc. Common Stock | 0.17 USD | +6.25% | -5.56% | -19.05% | -93.61% | 5.18 M USD | ||
| 4814 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.17 USD | +3.59% | -12.19% | -50.08% | +166.39% | 5.16 M USD | ||
| 4815 |  PULM Pulmatrix, Inc. - Common Stock | 1.41 USD | +2.92% | -4.08% | +0.71% | -70.00% | 5.15 M USD | ||
| 4821 |  TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 USD | +19.97% | +23.52% | +13.29% | +685.15% | 4.95 M USD | ||
| 4822 |  LEXX Lexaria Bioscience Corp. - Common Stock | 2.99 USD | +6.03% | -9.67% | -2.61% | +255.95% | 4.94 M USD | ||
| 4829 |  LGVN Longeveron Inc. - Class A Common stock | 1.50 USD | -13.29% | -37.50% | -52.23% | +163.16% | 4.78 M USD | ||
| 4831 |  CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.68 USD | -10.02% | -4.91% | +4.84% | +60.00% | 4.71 M USD | ||
| 4832 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.99 USD | +5.85% | +0.51% | -15.32% | +121.11% | 4.71 M USD | ||
| 4833 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.68 USD | +3.70% | +32.28% | -9.19% | -24.32% | 4.69 M USD | ||
| 4835 |  XBIO Xenetic Biosciences, Inc. - Common Stock | 2.00 USD | -4.76% | -9.50% | -11.89% | -53.27% | 4.69 M USD | ||
| 4840 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.56 USD | +3.70% | -11.11% | -29.11% | -89.87% | 4.59 M USD | ||
| 4844 |  CODX Co-Diagnostics, Inc. - Common Stock | 0.72 USD | -5.26% | -33.94% | -26.53% | -77.50% | 4.50 M USD | ||
| 4847 |  INBS Intelligent Bio Solutions Inc. - Common Stock | 1.44 USD | -0.69% | -8.86% | -26.90% | -70.49% | 4.36 M USD | ||
| 4851 |  ITOC iTonic Holdings Ltd - Class A Ordinary Shares | 4.05 USD | +6.58% | -0.98% | +1346.43% | +350.00% | 4.32 M USD | ||
| 4852 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.21 USD | -1.23% | -9.58% | -4.18% | +163.11% | 4.31 M USD | ||
| 4854 |  NCNA NuCana plc - American Depositary Shares | 1.02 USD | -2.86% | -9.73% | -23.31% | -52.56% | 4.25 M USD |
Nachrichten Aktien aus dem Gesundheitswesen
Organon präsentiert Daten aus seiner laufenden Phase-3-Studie des Intrauterinpessars MIUDELLA auf der Jahresversammlung 2026 der Society of Family Planning
Ironwood Pharmaceuticals ernennt Tammi Gaskins zur CEO, wirksam ab dem 1. Januar 2027
Eli Lilly erhält positive CHMP-Stellungnahme der EMA mit Empfehlung zur Marktzulassung von Foundayo zur Behandlung von Typ-2-Diabetes mellitus und zur Gewichtskontrolle
Needham bekräftigt Kaufempfehlung für Neurocrine Biosciences und hält am Kursziel von 204 US-Dollar fest
Tiziana Life Sciences beginnt mit der Dosierung des letzten Patienten in seiner klinischen Phase-2-Studie zur Bewertung von intranasalem Foralumab bei Patienten mit früher/leichter Alzheimer-Krankheit; Topline-Daten werden für Q1 2027 erwartet
Tango Therapeutics wird auf dem ESMO-Kongress 2026 aktualisierte Daten aus der Phase-1/2-Studie von Vopimetostat in Kombination mit Daraxonrasib oder Zoldonrasib bei Patienten mit MTAPdel/RASmut-metastasiertem PDAC und NSCLC vorstellen
Regeneron Pharma sagt, dass der CHMP der EMA eine positive Stellungnahme zur Empfehlung der Zulassung eines alternativen Dosierungsschemas für Libtayo in allen zugelassenen Indikationen angenommen hat
Gewinner Aktien aus dem Gesundheitswesen
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Verlierer Aktien aus dem Gesundheitswesen
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |